U.S. markets open in 5 hours 12 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
765.42+1.15 (+0.15%)
At close: 04:00PM EST
763.00 -2.42 (-0.32%)
After hours: 04:32PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close764.27
Bid0.00 x 800
Ask0.00 x 1000
Day's Range758.08 - 779.00
52 Week Range538.01 - 779.00
Avg. Volume726,842
Market Cap83.356B
Beta (5Y Monthly)0.21
PE Ratio (TTM)16.32
EPS (TTM)46.91
Earnings DateFeb 02, 2023 - Feb 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est802.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for REGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Regeneron Pharmaceuticals, Inc.
    Technical Assessment: Bullish in the Intermediate-TermThe stock market has taken two consecutive body shots and is starting to look wobbly. The S&P 500 (SPX) has broken down from its bullish channel off the October lows and is under its prior low from late November. The five-day/13-day exponential moving average crossover system is close to turning bearish after a very good run since its last bullish signal on October 21. The 14-day relative strength index (RSI) also has broken its uptrend off its lows since late September.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more